Pharmascience has announced the launch of a new stand-alone company focused on leading growth within the over-the-counter (OTC) category with its OTC brands such as Helixia, Lax-A-Day, Hemovel, Cromolyn, Cystoplus and Rhinaris. This new company is called Norwell Consumer Healthcare Inc.
OTC products have been an important part of Pharmascience. By launching a more streamlined and targeted organization focused only on OTC brands, Norwell will have the agility and flexibility to drive the growth of its current OTC brands and launch new innovations into the Canadian marketplace.
Norwell’s vision is to help Canadians manage their health and wellness needs by offering trusted, clinically proven OTC solutions.
“Launching Norwell Consumer Healthcare provides a focused and experienced OTC team that is energized with the opportunity to grow our brands, bringing innovative solutions to the market and helping Canadians with their health and wellness needs,” said David Bloom, General Manager, Norwell Consumer Healthcare Inc.
“We hold high expectations for this new venture and will spare no effort supporting Norwell in providing top quality brands and services to our consumers, patients, and customers,” said David Goodman, CEO of Pharmascience Inc.
